1、 ARIFULLAH M, NAMSA N D, MANDAL M, et al. Evaluation of anti-bacterial and anti-oxidant potential of andrographolide and echiodinin isolated from callus culture of Andrographis paniculata Nees[J]. Asian Pac J Trop Biomed, 2013, 3(8): 604-610. ARIFULLAH M, NAMSA N D, MANDAL M, et al. Evaluation of anti-bacterial and anti-oxidant potential of andrographolide and echiodinin isolated from callus culture of Andrographis paniculata Nees[J]. Asian Pac J Trop Biomed, 2013, 3(8): 604-610.
2、 WHITE A J, GOMPERTZ S, STOCKLEY R A. Chronic obstructive pulmonary disease. 6: The aetiology of exacerbations of chronic obstructive pulmonary disease[J]. Thorax, 2003, 58(1): 73-80. WHITE A J, GOMPERTZ S, STOCKLEY R A. Chronic obstructive pulmonary disease. 6: The aetiology of exacerbations of chronic obstructive pulmonary disease[J]. Thorax, 2003, 58(1): 73-80.
3、 WEDZICHA J A, SEEMUNGAL T A R. COPD exacerbations: defining their cause and prevention[J]. Lancet, 2007, 370(9589): 786-796. WEDZICHA J A, SEEMUNGAL T A R. COPD exacerbations: defining their cause and prevention[J]. Lancet, 2007, 370(9589): 786-796.
4、 SOLER N, TORRES A, EWIG S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation[J]. Am J Respir Crit Care Med, 1998, 157(5): 1498-1505. SOLER N, TORRES A, EWIG S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation[J]. Am J Respir Crit Care Med, 1998, 157(5): 1498-1505.
5、 BAO Z, GUAN S, CHENG C, et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-κB pathway[J]. Am J Respir Crit Care Med, 2009, 179(8): 657-665. BAO Z, GUAN S, CHENG C, et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-κB pathway[J]. Am J Respir Crit Care Med, 2009, 179(8): 657-665.
6、 CHEN H W, LIN A H, CHU H C, et al. Inhibition of TNF-α-induced inflammation by andrographolide via down-regulation of the PI3K/Akt signaling pathway[J]. J Nat Prod, 2011, 74(11): 2408-2413. CHEN H W, LIN A H, CHU H C, et al. Inhibition of TNF-α-induced inflammation by andrographolide via down-regulation of the PI3K/Akt signaling pathway[J]. J Nat Prod, 2011, 74(11): 2408-2413.
7、 LI F, LI S. Effects of andrographolide on the activation of mitogen activated protein kinases and nuclear factor-κB in mouse peritoneal macrophage-derived foam cells[J]. Chin J Integr Med, 2012, 18(5): 391-394. LI F, LI S. Effects of andrographolide on the activation of mitogen activated protein kinases and nuclear factor-κB in mouse peritoneal macrophage-derived foam cells[J]. Chin J Integr Med, 2012, 18(5): 391-394.
8、 LEE K C, CHANG H H, CHUNG Y H, et al. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway[J]. J Ethnopharmacol, 2011, 135(3): 678-684. LEE K C, CHANG H H, CHUNG Y H, et al. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway[J]. J Ethnopharmacol, 2011, 135(3): 678-684.
9、 VOGELMEIER C F, CRINER G J, MARTINEZ F J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary[J]. Am J Respir Crit Care Med, 2017, 195(5): 557-582. VOGELMEIER C F, CRINER G J, MARTINEZ F J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary[J]. Am J Respir Crit Care Med, 2017, 195(5): 557-582.
10、 郑劲平, 高怡. 肺功能检查实用指南[M]. 北京: 人民卫生出版社, 2009. 郑劲平, 高怡. 肺功能检查实用指南[M]. 北京: 人民卫生出版社, 2009.
11、 HERESI G A, AYTEKIN M, HAMMEL J P, et al. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension[J]. Eur Respir J, 2014, 43(3): 912-914. HERESI G A, AYTEKIN M, HAMMEL J P, et al. Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension[J]. Eur Respir J, 2014, 43(3): 912-914.
12、 ANSARIN K, RASHIDI F, NAMDAR H, et al. Echocardiographic evaluation of the relationship between inflammatory factors (IL6, TNFα, hs-CRP) and secondary pulmonary hypertension in patients with COPD. A cross sectional study[J]. Pneumologia, 2015, 64(3): 31-35. ANSARIN K, RASHIDI F, NAMDAR H, et al. Echocardiographic evaluation of the relationship between inflammatory factors (IL6, TNFα, hs-CRP) and secondary pulmonary hypertension in patients with COPD. A cross sectional study[J]. Pneumologia, 2015, 64(3): 31-35.
13、 SINGH S, VERMA S K, KUMAR S, et al. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers[J]. Immunol Lett, 2018(196): 1-10. SINGH S, VERMA S K, KUMAR S, et al. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers[J]. Immunol Lett, 2018(196): 1-10.
14、 王丽,谭焰,谷伟,等.慢性阻塞性肺病缓解期患者血清中TNF-α、IL-6和IL-8表达的研究[J].临床肺科杂志,2011,16(6):835-836. 王丽,谭焰,谷伟,等.慢性阻塞性肺病缓解期患者血清中TNF-α、IL-6和IL-8表达的研究[J].临床肺科杂志,2011,16(6):835-836.
15、 LEE H. Procalcitonin as a biomarker of infectious diseases[J]. Korean J Intern Med, 2013, 28(3): 285. LEE H. Procalcitonin as a biomarker of infectious diseases[J]. Korean J Intern Med, 2013, 28(3): 285.
16、 LIU H H, ZHANG M W, GUO J B, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria[J]. Ir J Med Sci, 2017, 186(1): 207-212. LIU H H, ZHANG M W, GUO J B, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria[J]. Ir J Med Sci, 2017, 186(1): 207-212.
17、 MüLLER B, HARBARTH S, STOLZ D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia[J]. BMC Infect Dis, 2007, 7(1): 10. MüLLER B, HARBARTH S, STOLZ D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia[J]. BMC Infect Dis, 2007, 7(1): 10.
18、 SCHUETZ P, CHRIST-CRAIN M, THOMANN R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial[J]. JAMA, 2009, 302(10): 1059-1066. SCHUETZ P, CHRIST-CRAIN M, THOMANN R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial[J]. JAMA, 2009, 302(10): 1059-1066.
19、 RIEDEL S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis[J]. Diagn Microbiol Infect Dis, 2012, 73(3): 221-227. RIEDEL S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis[J]. Diagn Microbiol Infect Dis, 2012, 73(3): 221-227.
20、 LINDER R, ROMMARK E, POURAZAR J, et al. Serum metalloproteinase-9 is related to COPD severity and symptoms-cross-sectional data from a population based cohort-study[J]. Respir Res, 2015, 16(1): 28. LINDER R, ROMMARK E, POURAZAR J, et al. Serum metalloproteinase-9 is related to COPD severity and symptoms-cross-sectional data from a population based cohort-study[J]. Respir Res, 2015, 16(1): 28.
21、 PAPAKONSTANTINOU E, KARAKIULAKIS G, BATZIOS S, et al. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection[J]. Respir Res, 2015, 16(1): 78. PAPAKONSTANTINOU E, KARAKIULAKIS G, BATZIOS S, et al. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection[J]. Respir Res, 2015, 16(1): 78.
22、 WOODE D, SHIOMI T, D'ARMIENTO J. Collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer[J]. Cancers, 2015, 7(1): 329-341. WOODE D, SHIOMI T, D'ARMIENTO J. Collagenolytic matrix metalloproteinases in chronic obstructive lung disease and cancer[J]. Cancers, 2015, 7(1): 329-341.
23、 CHAUDHURI R, MCSHARRY C, BRADY J, et al. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma[J]. Eur Respir J, 2014, 44(4):895-904. CHAUDHURI R, MCSHARRY C, BRADY J, et al. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma[J]. Eur Respir J, 2014, 44(4):895-904.
24、 SORIANO J B, ABAJOBIR A A, ABATEK H, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet Respir Med, 2017, 5(9): 691-706. SORIANO J B, ABAJOBIR A A, ABATEK H, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet Respir Med, 2017, 5(9): 691-706.
25、 新型冠状病毒感染的肺炎诊疗方案(第六版试行)[S]. 国家卫生健康委办公厅,2020. 新型冠状病毒感染的肺炎诊疗方案(第六版试行)[S]. 国家卫生健康委办公厅,2020.
26、 WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717. WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
